세계의 펜타닐 시장 규모 조사 및 예측 : 투여 경로별, 최종사용자별, 지역별 분석(2023-2030년)

The market growth of cancer-related products and services is strongly influenced by the increasing prevalence of cancer globally. In 2022, the United States is estimated to witness approximately 1.9 million newly diagnosed cancer cases, emphasizing the significant impact of this disease on individuals and communities within the country. Additionally, it is projected that there will be 609,360 cancer-related deaths in the same year. The rising awareness of cancer, coupled with advancements in medical research and the development of new treatments, further contributes to the growth of the market. Governments worldwide are recognizing the urgent need to address cancer as a leading cause of premature death, leading to increased investment in initiatives and programs aimed at reducing cancer mortality rates.

The combination of these factors, including the increasing prevalence of cancer, heightened awareness, advancements in treatments, and greater investment in medical research, collectively drive the market growth of cancer-related products and services. As the global fight against cancer intensifies, the market is poised to expand to meet the growing demand for effective prevention, diagnosis, treatment, and supportive care.

Furthermore, the projected rise in global healthcare expenditure is anticipated to drive the expansion of the global fentanyl market. Industry experts have indicated that the average total health spending per person worldwide was approximately USD 1,129 USD in 2019. This figure is estimated to grow to USD 1,515 by 2050. The increase in healthcare spending signifies a greater allocation of resources towards medical treatments and pharmaceuticals, which is likely to contribute to the growth of the fentanyl market. Moreover, the implementation of awareness campaigns focusing on the therapeutic benefits of fentanyl is expected to further enhance the market's potential for expansion during the forecast period. These campaigns aim to educate healthcare professionals and the public about the appropriate and responsible use of fentanyl in managing pain and improving patient outcomes. By increasing awareness about the safe and effective utilization of fentanyl, these initiatives can potentially stimulate demand for the product and drive market growth.

The key regions considered for the Global Fentanyl Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. By the end of 2030, the North American fentanyl market is projected to capture the largest market share. This dominance in the region can be attributed to several factors, including population growth, research activities, and the availability of health insurance coverage for various cancer diagnoses. The region's growing population provides a larger patient pool for medical treatments, including fentanyl usage. Additionally, the presence of extensive research activities in North America supports the development and adoption of advanced pharmaceuticals, including fentanyl, further driving market growth.

The rising economic status and affordability of advanced cancer treatments in North America also contribute to market expansion. The United States, for instance, witnessed an increase in personal income and spending, indicating the financial capacity to access advanced treatments. In 2019, the country reported a significant number of new cancer cases and cancer-related deaths, underlining the demand for effective pain management options such as fentanyl. Furthermore, insurance companies in North America offer efficient reimbursement policies for cancer treatments, incentivizing patients to opt for advanced treatment methods. This favorable reimbursement environment plays a significant role in encouraging patients to choose fentanyl and other advanced therapies, thus contributing to the market's growth in the region.

Major market player included in this report are:

• Thermo Fisher Scientific Inc.
• Boehringer Ingelheim GmbH
• Bayer AG
• Novartis AG
• Sanofi-aventis Groupe
• Abbott Laboratories
• Merck & Co., Inc.
• Validus Pharmaceuticals LLC
• Teva Pharmaceutical Industries Ltd.
• Siemens Healthcare GmbH

Global Fentanyl Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Route of administration, Enduse and Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

• Sublingual Tablet
• Buccal Tablet
• Oral Film
• Others

By Enduse:

• Hospital
• Oncology Centers
• Surgical Centers
• Others

By Region:

• North America
• U.S.
• Canada

• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

• Latin America
• Brazil
• Mexico

• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Fentanyl Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Fentanyl Market, by Route of Administration, 2020-2030 (USD Billion)
  • 1.2.3. Fentanyl Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Fentanyl Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Fentanyl Market Dynamics

• 3.1. Fentanyl Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing Geriatric Population
    • 3.1.1.2. Worldwide Prevalence of Cancer
  • 3.1.2. Market Challenges
    • 3.1.2.1. Side effects associated with a high dose of fentanyl
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rise in Research Spending

Chapter 4. Global Fentanyl Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Fentanyl Market, by Route of Administration

• 5.1. Market Snapshot
• 5.2. Global Fentanyl Market by Route of Administration, Performance - Potential Analysis
• 5.3. Global Fentanyl Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
• 5.4. Fentanyl Market, Sub Segment Analysis
  • 5.4.1. Sublingual Tablet
  • 5.4.2. Buccal Tablet
  • 5.4.3. Oral Film
  • 5.4.4. Others

Chapter 6. Global Fentanyl Market, by End User

• 6.1. Market Snapshot
• 6.2. Global Fentanyl Market by End User, Performance - Potential Analysis
• 6.3. Global Fentanyl Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 6.4. Fentanyl Market, Sub Segment Analysis
  • 6.4.1. Hospital
  • 6.4.2. Oncology Centres
  • 6.4.3. Surgical Centres
  • 6.4.4. Others

Chapter 7. Global Fentanyl Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Fentanyl Market, Regional Market Snapshot
• 7.4. North America Fentanyl Market
  • 7.4.1. U.S. Fentanyl Market
    • 7.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Fentanyl Market
• 7.5. Europe Fentanyl Market Snapshot
  • 7.5.1. U.K. Fentanyl Market
  • 7.5.2. Germany Fentanyl Market
  • 7.5.3. France Fentanyl Market
  • 7.5.4. Spain Fentanyl Market
  • 7.5.5. Italy Fentanyl Market
  • 7.5.6. Rest of Europe Fentanyl Market
• 7.6. Asia-Pacific Fentanyl Market Snapshot
  • 7.6.1. China Fentanyl Market
  • 7.6.2. India Fentanyl Market
  • 7.6.3. Japan Fentanyl Market
  • 7.6.4. Australia Fentanyl Market
  • 7.6.5. South Korea Fentanyl Market
  • 7.6.6. Rest of Asia Pacific Fentanyl Market
• 7.7. Latin America Fentanyl Market Snapshot
  • 7.7.1. Brazil Fentanyl Market
  • 7.7.2. Mexico Fentanyl Market
• 7.8. Middle East & Africa Fentanyl Market
  • 7.8.1. Saudi Arabia Fentanyl Market
  • 7.8.2. South Africa Fentanyl Market
  • 7.8.3. Rest of Middle East & Africa Fentanyl Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Thermo Fisher Scientific Inc.
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Boehringer Ingelheim GmbH
  • 8.3.3. Bayer AG
  • 8.3.4. Novartis AG
  • 8.3.5. Sanofi-aventis Groupe
  • 8.3.6. Abbott Laboratories
  • 8.3.7. Merck & Co., Inc.
  • 8.3.8. Validus Pharmaceuticals LLC
  • 8.3.9. Teva Pharmaceutical Industries Ltd.
  • 8.3.10. Siemens Healthcare GmbH

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption